" class="no-js "lang="en-US"> HLH/MAS Archives - Medtech Alert
Thursday, February 02, 2023

Sort by:

Date

Top Post

NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition

The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]

FDA Approves Abecma for Multiple Myeloma

The U.S. Food and Drug Administration approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to […]

  1. Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer Read more
  2. iCRYO Announces Partnership with Therapeutic Manufacturer, BTL Read more
  3. Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-MMP7 for Treatment of Idiopathic Pulmonary Fibrosis Read more
  4. Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-restricted ALK5 Inhibitor for Fibrostenosing Crohn’s Disease Read more
  5. Poseida Therapeutics Announces Board Change Read more